211 related articles for article (PubMed ID: 20512044)
1. Improved detection of CXCR4-using HIV by V3 genotyping: application of population-based and "deep" sequencing to plasma RNA and proviral DNA.
Swenson LC; Moores A; Low AJ; Thielen A; Dong W; Woods C; Jensen MA; Wynhoven B; Chan D; Glascock C; Harrigan PR
J Acquir Immune Defic Syndr; 2010 Aug; 54(5):506-10. PubMed ID: 20512044
[TBL] [Abstract][Full Text] [Related]
2. Population-based V3 genotypic tropism assay: a retrospective analysis using screening samples from the A4001029 and MOTIVATE studies.
McGovern RA; Thielen A; Mo T; Dong W; Woods CK; Chapman D; Lewis M; James I; Heera J; Valdez H; Harrigan PR
AIDS; 2010 Oct; 24(16):2517-25. PubMed ID: 20736814
[TBL] [Abstract][Full Text] [Related]
3. Comparative determination of HIV-1 co-receptor tropism by Enhanced Sensitivity Trofile, gp120 V3-loop RNA and DNA genotyping.
Prosperi MC; Bracciale L; Fabbiani M; Di Giambenedetto S; Razzolini F; Meini G; Colafigli M; Marzocchetti A; Cauda R; Zazzi M; De Luca A
Retrovirology; 2010 Jun; 7():56. PubMed ID: 20591141
[TBL] [Abstract][Full Text] [Related]
4. Evolution of proviral DNA HIV-1 tropism under selective pressure of maraviroc-based therapy.
Baroncelli S; Galluzzo CM; Weimer LE; Pirillo MF; Volpe A; Mercuri A; Cavalli A; Fragola V; Monno L; Degli Antoni A; Ladisa N; Francisci D; Bucciardini R; Floridia M
J Antimicrob Chemother; 2012 Jun; 67(6):1479-85. PubMed ID: 22361986
[TBL] [Abstract][Full Text] [Related]
5. Prediction of HIV-1 coreceptor usage (tropism) by sequence analysis using a genotypic approach.
Sierra S; Kaiser R; Lübke N; Thielen A; Schuelter E; Heger E; Däumer M; Reuter S; Esser S; Fätkenheuer G; Pfister H; Oette M; Lengauer T
J Vis Exp; 2011 Dec; (58):. PubMed ID: 22157596
[TBL] [Abstract][Full Text] [Related]
6. Performance of genotypic algorithms for predicting HIV-1 tropism measured against the enhanced-sensitivity Trofile coreceptor tropism assay.
Sánchez V; Masiá M; Robledano C; Padilla S; Ramos JM; Gutiérrez F
J Clin Microbiol; 2010 Nov; 48(11):4135-9. PubMed ID: 20861336
[TBL] [Abstract][Full Text] [Related]
7. Correlation between genotypic (V3 population sequencing) and phenotypic (Trofile ES) methods of characterizing co-receptor usage of HIV-1 from 200 treatment-naïve HIV patients screened for Study A4001078.
Portsmouth S; Valluri SR; Däumer M; Thiele B; Valdez H; Lewis M; Craig C; Thielen A; James I; Demarest J; Heera J
Antiviral Res; 2013 Jan; 97(1):60-5. PubMed ID: 23165088
[TBL] [Abstract][Full Text] [Related]
8. Deep sequencing to infer HIV-1 co-receptor usage: application to three clinical trials of maraviroc in treatment-experienced patients.
Swenson LC; Mo T; Dong WW; Zhong X; Woods CK; Jensen MA; Thielen A; Chapman D; Lewis M; James I; Heera J; Valdez H; Harrigan PR
J Infect Dis; 2011 Jan; 203(2):237-45. PubMed ID: 21288824
[TBL] [Abstract][Full Text] [Related]
9. Genotypic analysis of the V3 region of HIV from virologic nonresponders to maraviroc-containing regimens reveals distinct patterns of failure.
Swenson LC; Chui CK; Brumme CJ; Chan D; Woods CK; Mo T; Dong W; Chapman D; Lewis M; Demarest JF; James I; Portsmouth S; Goodrich J; Heera J; Valdez H; Harrigan PR
Antimicrob Agents Chemother; 2013 Dec; 57(12):6122-30. PubMed ID: 24080655
[TBL] [Abstract][Full Text] [Related]
10. Sensitive cell-based assay for determination of human immunodeficiency virus type 1 coreceptor tropism.
Weber J; Vazquez AC; Winner D; Gibson RM; Rhea AM; Rose JD; Wylie D; Henry K; Wright A; King K; Archer J; Poveda E; Soriano V; Robertson DL; Olivo PD; Arts EJ; Quiñones-Mateu ME
J Clin Microbiol; 2013 May; 51(5):1517-27. PubMed ID: 23486708
[TBL] [Abstract][Full Text] [Related]
11. High sensitivity of specific genotypic tools for detection of X4 variants in antiretroviral-experienced patients suitable to be treated with CCR5 antagonists.
Seclén E; Garrido C; González Mdel M; González-Lahoz J; de Mendoza C; Soriano V; Poveda E
J Antimicrob Chemother; 2010 Jul; 65(7):1486-92. PubMed ID: 20427374
[TBL] [Abstract][Full Text] [Related]
12. Deep V3 sequencing for HIV type 1 tropism in treatment-naive patients: a reanalysis of the MERIT trial of maraviroc.
Swenson LC; Mo T; Dong WW; Zhong X; Woods CK; Thielen A; Jensen MA; Knapp DJ; Chapman D; Portsmouth S; Lewis M; James I; Heera J; Valdez H; Harrigan PR
Clin Infect Dis; 2011 Oct; 53(7):732-42. PubMed ID: 21890778
[TBL] [Abstract][Full Text] [Related]
13. Use of four next-generation sequencing platforms to determine HIV-1 coreceptor tropism.
Archer J; Weber J; Henry K; Winner D; Gibson R; Lee L; Paxinos E; Arts EJ; Robertson DL; Mimms L; Quiñones-Mateu ME
PLoS One; 2012; 7(11):e49602. PubMed ID: 23166726
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of a Genotypic Assay to Quantify CXCR4- and CCR5-Tropic Human Immunodeficiency Virus Type-1 (HIV-1) Populations and a Comparison to Trofile
Ko D; McLaughlin S; Deng W; Mullins JI; Dragavon J; Harb S; Coombs RW; Frenkel LM
Viruses; 2024 Mar; 16(4):. PubMed ID: 38675853
[TBL] [Abstract][Full Text] [Related]
15. A genotypic test for HIV-1 tropism combining Sanger sequencing with ultradeep sequencing predicts virologic response in treatment-experienced patients.
Kagan RM; Johnson EP; Siaw M; Biswas P; Chapman DS; Su Z; Platt JL; Pesano RL
PLoS One; 2012; 7(9):e46334. PubMed ID: 23029482
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with proviral DNA HIV-1 tropism in antiretroviral therapy-treated patients with fully suppressed plasma HIV viral load: implications for the clinical use of CCR5 antagonists.
Soulié C; Fourati S; Lambert-Niclot S; Malet I; Wirden M; Tubiana R; Valantin MA; Katlama C; Calvez V; Marcelin AG
J Antimicrob Chemother; 2010 Apr; 65(4):749-51. PubMed ID: 20150182
[TBL] [Abstract][Full Text] [Related]
17. Maraviroc treatment in non-R5-HIV-1-infected patients results in the selection of extreme CXCR4-using variants with limited effect on the total viral setpoint.
McGovern RA; Symons J; Poon AF; Harrigan PR; van Lelyveld SF; Hoepelman AI; van Ham PM; Dong W; Wensing AM; Nijhuis M
J Antimicrob Chemother; 2013 Sep; 68(9):2007-14. PubMed ID: 23677920
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 tropism: a comparison between RNA and proviral DNA in routine clinical samples from Chilean patients.
Ferrer P; Montecinos L; Tello M; Tordecilla R; Rodríguez C; Ferrés M; Pérez CM; Beltrán C; Guzmán MA; Afani A
Virol J; 2013 Oct; 10():318. PubMed ID: 24165156
[TBL] [Abstract][Full Text] [Related]
19. Comparison of genotypic and phenotypic HIV type 1 tropism assay: results from the screening samples of Cenicriviroc Study 202, a randomized phase II trial in treatment-naive subjects.
Kagan RM; Johnson EP; Siaw MF; Van Baelen B; Ogden R; Platt JL; Pesano RL; Lefebvre E
AIDS Res Hum Retroviruses; 2014 Feb; 30(2):151-9. PubMed ID: 23875707
[TBL] [Abstract][Full Text] [Related]
20. High concordance of genotypic coreceptor prediction in plasma-viral RNA and proviral DNA of HIV-1 subtype C: implications for use of whole blood DNA in resource-limited settings.
Gupta S; Neogi U; Srinivasa H; Shet A
J Antimicrob Chemother; 2013 Sep; 68(9):2003-6. PubMed ID: 23633683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
